What is Covetrus?
Headquartered in Portland, Maine, Covetrus operates as a comprehensive technology and services provider for the global veterinary industry. The company distinguishes itself by offering an integrated ecosystem that addresses both the clinical and financial requirements of veterinary practices. Its core offering, the Pulse Veterinary Operating System, functions as a centralized hub for scheduling, prescription fulfillment, and client communication, effectively digitizing the workflow for over 100,000 customers.
Beyond software, Covetrus provides a robust supply chain management platform, facilitating access to compounded medications and essential in-clinic supplies. By consolidating these disparate functions into a single, cohesive solution, the firm enables veterinary professionals to optimize their practice performance and improve patient outcomes. With a legacy spanning over six decades, the company remains a pivotal partner in the evolution of companion, equine, and large-animal care.
How much funding has Covetrus raised?
Covetrus has raised a total of $4.7B across 3 funding rounds:
Debt
$250M
Private Equity
$4B
Debt
$425M
Debt (2020): $250M with participation from Clayton Dubilier & Rice LLC
Private Equity (2022): $4B led by Clayton, Dubilier & Rice and TPG
Debt (2022): $425M, investors not publicly disclosed
Key Investors in Covetrus
Clayton Dubilier & Rice LLC
A prominent private equity firm that focuses on building stronger, more profitable businesses through operational expertise and strategic capital investment.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Covetrus?
With the recent capital deployment, Covetrus is well-positioned to accelerate its digital transformation initiatives and expand its footprint in the veterinary technology market. The strategic focus will likely center on enhancing the capabilities of the Pulse platform and deepening the integration of its prescription fulfillment services. As the company leverages its recent financing, stakeholders can expect a continued emphasis on scaling its supply chain infrastructure to meet the growing demand for efficient, technology-driven veterinary care.
Furthermore, the firm is poised to capitalize on its extensive customer base by introducing advanced data analytics and improved client engagement tools. By maintaining its focus on clinical and financial outcomes, Covetrus aims to sustain its growth trajectory and reinforce its status as a leader in the global animal health services sector.
